The DTaP and Tdap Vaccines Market is expected to register a CAGR of 5.3% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The DTaP and Tdap Vaccines Market report covers segmental analysis by Product Type (DTaP vaccine (Diphtheria-Tetanus-acellular Pertussis vaccine), TD (Tetanus and Diphtheria) vaccine, Tdap (Tetanus-Diphtheria-Acellular Pertussis) vaccine); Age Group (Adult, Pediatric); End user (Hospitals, Clinics, Vaccination Centers), and geography, and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report DTaP and Tdap Vaccines Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
DTaP and Tdap Vaccines Market Segmentation
Product Type- DTaP vaccine
- TD vaccine
- Tdap vaccine
- Adult
- Pediatric
- Hospitals
- Clinics
- Vaccination Centers
Strategic Insights
DTaP and Tdap Vaccines Market Growth Drivers- Government Mandates and Immunization Schedules: Many governments worldwide have made it mandatory for children to receive the DTaP vaccine as part of their routine immunization schedules. Such mandates help to expand the market for DTaP vaccines by increasing vaccination rates, ensuring that children are protected against infectious diseases at an early age. Similarly, adult Tdap vaccinations are increasingly recommended, especially for pregnant women and healthcare workers, fostering growth in the Tdap vaccine market.
- Increase in Pertussis and Tetanus Cases: The rising number of pertussis outbreaks in some regions and the persistent risk of tetanus infections, especially in underdeveloped or rural areas, is a key growth driver for the DTaP and Tdap vaccines market. These diseases can lead to serious health complications or even death, motivating individuals and health organizations to prioritize vaccination, thereby fueling demand for both DTaP and Tdap vaccines.
- Increased Focus on Maternal Immunization: The growing emphasis on maternal immunization has significantly impacted the Tdap vaccine market. Health authorities now recommend that pregnant women receive the Tdap vaccine to protect newborns from pertussis. The rising recognition of maternal immunization as a critical public health strategy has created a new market segment, driving the demand for Tdap vaccines among expecting mothers.
- Enhanced Vaccination for Pregnant Women: The growing trend of vaccinating pregnant women to protect both the mother and infant from diseases like pertussis will continue to expand the Tdap vaccines market. Health authorities are increasingly recommending Tdap vaccination during each pregnancy, regardless of prior vaccination history. As maternal immunization gains traction and becomes a standard part of prenatal care, the demand for Tdap vaccines is anticipated to rise significantly, contributing to both maternal and child health.
- Personalized Vaccine Schedules Based on Genetic Insights: Advances in genomics and personalized medicine are expected to influence the future of the DTaP and Tdap vaccines market. Personalized vaccination schedules, tailored to individual genetic profiles and immune responses, could become more commonplace. This will allow healthcare providers to optimize the timing and dosing of vaccines for better protection, especially for individuals with compromised immune systems. As personalized healthcare becomes a larger trend, the demand for vaccines that can be customized will create new opportunities for the market.
- Expanded Focus on Booster Shots for Adults: As immunity from vaccines such as DTaP and Tdap wanes over time, booster shots will become more of a focus in the coming years, particularly for adults. Future trends indicate a growing emphasis on the regular administration of booster shots to maintain immunity against diseases like tetanus, diphtheria, and pertussis. This trend will expand the market for Tdap vaccines among older populations and healthcare workers who are at higher risk of exposure to these diseases, reinforcing the need for lifelong vaccination.
- Collaborations with Non-Governmental Organizations (NGOs): Collaborating with non-governmental organizations (NGOs) that focus on global health is an opportunity for vaccine manufacturers to increase the distribution of DTaP and Tdap vaccines. NGOs can help provide funding and infrastructure in developing countries, accelerating the distribution of vaccines to populations that are otherwise hard to reach. This partnership can help build market share in regions with limited healthcare infrastructure and increase the overall impact of vaccination programs.
- Vaccine Advocacy and Public Health Leadership: As public health leaders and organizations continue to advocate for vaccinations as essential public health tools, there is a growing opportunity to influence policy and healthcare practices to favor DTaP and Tdap vaccines. As public health campaigns become more aggressive and coordinated, advocating for the importance of vaccination in preventing infectious diseases, the DTaP and Tdap vaccines market is expected to see more widespread adoption.
- Longer-Term Immunity and Reduced Booster Needs: There is an opportunity for the DTaP and Tdap vaccines market to grow by focusing on the development of vaccines that provide longer-lasting immunity. If DTaP and Tdap vaccines could reduce the need for frequent booster shots, this would not only benefit patients but also lower healthcare costs associated with long-term immunization programs. A vaccine with extended immunity would enhance market appeal, particularly for individuals seeking fewer medical visits and for healthcare systems aiming to reduce vaccine administration costs.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the DTaP and Tdap Vaccines Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the DTaP and Tdap Vaccines Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The DTaP and Tdap Vaccines Market is expected to register a CAGR of 5.3% from 2025-2031.
The major factors impacting the DTaP and Tdap Vaccines Market are: Government Mandates and Immunization Schedules, Increase in Pertussis and Tetanus Cases and Increased Focus on Maternal Immunization
Key future trends in this market are - Enhanced Vaccination for Pregnant Women, Personalized Vaccine Schedules Based on Genetic Insights and Expanded Focus on Booster Shots for Adults
Key companies of this market are: AJ Vaccines, Bionet-Asia, GlaxoSmithKline plc (GSK), Johnson & Johnson, Massbiologics, Meiji Holdings Co., Ltd. (KM biologics co., Ltd., Merck & Co., Inc., Panacea Biotec Ltd., Sanofi, Serum Institute of India Pvt. Ltd.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 DTaP And Tdap Vaccines Market - By Product Type
1.3.2 DTaP And Tdap Vaccines Market - By Age Group
1.3.3 DTaP And Tdap Vaccines Market - By End user
1.3.4 DTaP And Tdap Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DTAP AND TDAP VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DTAP AND TDAP VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DTAP AND TDAP VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. DTAP AND TDAP VACCINES - GLOBAL MARKET OVERVIEW
6.2. DTAP AND TDAP VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DTAP AND TDAP VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DTAP VACCINE (DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINE)
7.3.1. Overview
7.3.2. DTaP vaccine (Diphtheria-Tetanus-acellular Pertussis vaccine) Market Forecast and Analysis
7.4. TD (TETANUS AND DIPHTHERIA) VACCINE
7.4.1. Overview
7.4.2. TD (Tetanus and Diphtheria) vaccine Market Forecast and Analysis
7.5. TDAP (TETANUS-DIPHTHERIA-ACELLULAR PERTUSSIS) VACCINE
7.5.1. Overview
7.5.2. Tdap (Tetanus-Diphtheria-Acellular Pertussis) vaccine Market Forecast and Analysis
8. DTAP AND TDAP VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - AGE GROUP
8.1. OVERVIEW
8.2. AGE GROUP MARKET FORECASTS AND ANALYSIS
8.3. ADULT
8.3.1. Overview
8.3.2. Adult Market Forecast and Analysis
8.4. PEDIATRIC
8.4.1. Overview
8.4.2. Pediatric Market Forecast and Analysis
9. DTAP AND TDAP VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. VACCINATION CENTERS
9.5.1. Overview
9.5.2. Vaccination Centers Market Forecast and Analysis
10. DTAP AND TDAP VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America DTaP And Tdap Vaccines Market Overview
10.1.2 North America DTaP And Tdap Vaccines Market Forecasts and Analysis
10.1.3 North America DTaP And Tdap Vaccines Market Forecasts and Analysis - By Product Type
10.1.4 North America DTaP And Tdap Vaccines Market Forecasts and Analysis - By Age Group
10.1.5 North America DTaP And Tdap Vaccines Market Forecasts and Analysis - By End user
10.1.6 North America DTaP And Tdap Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States DTaP And Tdap Vaccines Market
10.1.6.1.1 United States DTaP And Tdap Vaccines Market by Product Type
10.1.6.1.2 United States DTaP And Tdap Vaccines Market by Age Group
10.1.6.1.3 United States DTaP And Tdap Vaccines Market by End user
10.1.6.2 Canada DTaP And Tdap Vaccines Market
10.1.6.2.1 Canada DTaP And Tdap Vaccines Market by Product Type
10.1.6.2.2 Canada DTaP And Tdap Vaccines Market by Age Group
10.1.6.2.3 Canada DTaP And Tdap Vaccines Market by End user
10.1.6.3 Mexico DTaP And Tdap Vaccines Market
10.1.6.3.1 Mexico DTaP And Tdap Vaccines Market by Product Type
10.1.6.3.2 Mexico DTaP And Tdap Vaccines Market by Age Group
10.1.6.3.3 Mexico DTaP And Tdap Vaccines Market by End user
10.2. EUROPE
10.2.1 Europe DTaP And Tdap Vaccines Market Overview
10.2.2 Europe DTaP And Tdap Vaccines Market Forecasts and Analysis
10.2.3 Europe DTaP And Tdap Vaccines Market Forecasts and Analysis - By Product Type
10.2.4 Europe DTaP And Tdap Vaccines Market Forecasts and Analysis - By Age Group
10.2.5 Europe DTaP And Tdap Vaccines Market Forecasts and Analysis - By End user
10.2.6 Europe DTaP And Tdap Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany DTaP And Tdap Vaccines Market
10.2.6.1.1 Germany DTaP And Tdap Vaccines Market by Product Type
10.2.6.1.2 Germany DTaP And Tdap Vaccines Market by Age Group
10.2.6.1.3 Germany DTaP And Tdap Vaccines Market by End user
10.2.6.2 France DTaP And Tdap Vaccines Market
10.2.6.2.1 France DTaP And Tdap Vaccines Market by Product Type
10.2.6.2.2 France DTaP And Tdap Vaccines Market by Age Group
10.2.6.2.3 France DTaP And Tdap Vaccines Market by End user
10.2.6.3 Italy DTaP And Tdap Vaccines Market
10.2.6.3.1 Italy DTaP And Tdap Vaccines Market by Product Type
10.2.6.3.2 Italy DTaP And Tdap Vaccines Market by Age Group
10.2.6.3.3 Italy DTaP And Tdap Vaccines Market by End user
10.2.6.4 Spain DTaP And Tdap Vaccines Market
10.2.6.4.1 Spain DTaP And Tdap Vaccines Market by Product Type
10.2.6.4.2 Spain DTaP And Tdap Vaccines Market by Age Group
10.2.6.4.3 Spain DTaP And Tdap Vaccines Market by End user
10.2.6.5 United Kingdom DTaP And Tdap Vaccines Market
10.2.6.5.1 United Kingdom DTaP And Tdap Vaccines Market by Product Type
10.2.6.5.2 United Kingdom DTaP And Tdap Vaccines Market by Age Group
10.2.6.5.3 United Kingdom DTaP And Tdap Vaccines Market by End user
10.2.6.6 Rest of Europe DTaP And Tdap Vaccines Market
10.2.6.6.1 Rest of Europe DTaP And Tdap Vaccines Market by Product Type
10.2.6.6.2 Rest of Europe DTaP And Tdap Vaccines Market by Age Group
10.2.6.6.3 Rest of Europe DTaP And Tdap Vaccines Market by End user
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific DTaP And Tdap Vaccines Market Overview
10.3.2 Asia-Pacific DTaP And Tdap Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific DTaP And Tdap Vaccines Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific DTaP And Tdap Vaccines Market Forecasts and Analysis - By Age Group
10.3.5 Asia-Pacific DTaP And Tdap Vaccines Market Forecasts and Analysis - By End user
10.3.6 Asia-Pacific DTaP And Tdap Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia DTaP And Tdap Vaccines Market
10.3.6.1.1 Australia DTaP And Tdap Vaccines Market by Product Type
10.3.6.1.2 Australia DTaP And Tdap Vaccines Market by Age Group
10.3.6.1.3 Australia DTaP And Tdap Vaccines Market by End user
10.3.6.2 China DTaP And Tdap Vaccines Market
10.3.6.2.1 China DTaP And Tdap Vaccines Market by Product Type
10.3.6.2.2 China DTaP And Tdap Vaccines Market by Age Group
10.3.6.2.3 China DTaP And Tdap Vaccines Market by End user
10.3.6.3 India DTaP And Tdap Vaccines Market
10.3.6.3.1 India DTaP And Tdap Vaccines Market by Product Type
10.3.6.3.2 India DTaP And Tdap Vaccines Market by Age Group
10.3.6.3.3 India DTaP And Tdap Vaccines Market by End user
10.3.6.4 Japan DTaP And Tdap Vaccines Market
10.3.6.4.1 Japan DTaP And Tdap Vaccines Market by Product Type
10.3.6.4.2 Japan DTaP And Tdap Vaccines Market by Age Group
10.3.6.4.3 Japan DTaP And Tdap Vaccines Market by End user
10.3.6.5 South Korea DTaP And Tdap Vaccines Market
10.3.6.5.1 South Korea DTaP And Tdap Vaccines Market by Product Type
10.3.6.5.2 South Korea DTaP And Tdap Vaccines Market by Age Group
10.3.6.5.3 South Korea DTaP And Tdap Vaccines Market by End user
10.3.6.6 Rest of Asia-Pacific DTaP And Tdap Vaccines Market
10.3.6.6.1 Rest of Asia-Pacific DTaP And Tdap Vaccines Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific DTaP And Tdap Vaccines Market by Age Group
10.3.6.6.3 Rest of Asia-Pacific DTaP And Tdap Vaccines Market by End user
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa DTaP And Tdap Vaccines Market Overview
10.4.2 Middle East and Africa DTaP And Tdap Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa DTaP And Tdap Vaccines Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa DTaP And Tdap Vaccines Market Forecasts and Analysis - By Age Group
10.4.5 Middle East and Africa DTaP And Tdap Vaccines Market Forecasts and Analysis - By End user
10.4.6 Middle East and Africa DTaP And Tdap Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa DTaP And Tdap Vaccines Market
10.4.6.1.1 South Africa DTaP And Tdap Vaccines Market by Product Type
10.4.6.1.2 South Africa DTaP And Tdap Vaccines Market by Age Group
10.4.6.1.3 South Africa DTaP And Tdap Vaccines Market by End user
10.4.6.2 Saudi Arabia DTaP And Tdap Vaccines Market
10.4.6.2.1 Saudi Arabia DTaP And Tdap Vaccines Market by Product Type
10.4.6.2.2 Saudi Arabia DTaP And Tdap Vaccines Market by Age Group
10.4.6.2.3 Saudi Arabia DTaP And Tdap Vaccines Market by End user
10.4.6.3 U.A.E DTaP And Tdap Vaccines Market
10.4.6.3.1 U.A.E DTaP And Tdap Vaccines Market by Product Type
10.4.6.3.2 U.A.E DTaP And Tdap Vaccines Market by Age Group
10.4.6.3.3 U.A.E DTaP And Tdap Vaccines Market by End user
10.4.6.4 Rest of Middle East and Africa DTaP And Tdap Vaccines Market
10.4.6.4.1 Rest of Middle East and Africa DTaP And Tdap Vaccines Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa DTaP And Tdap Vaccines Market by Age Group
10.4.6.4.3 Rest of Middle East and Africa DTaP And Tdap Vaccines Market by End user
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America DTaP And Tdap Vaccines Market Overview
10.5.2 South and Central America DTaP And Tdap Vaccines Market Forecasts and Analysis
10.5.3 South and Central America DTaP And Tdap Vaccines Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America DTaP And Tdap Vaccines Market Forecasts and Analysis - By Age Group
10.5.5 South and Central America DTaP And Tdap Vaccines Market Forecasts and Analysis - By End user
10.5.6 South and Central America DTaP And Tdap Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil DTaP And Tdap Vaccines Market
10.5.6.1.1 Brazil DTaP And Tdap Vaccines Market by Product Type
10.5.6.1.2 Brazil DTaP And Tdap Vaccines Market by Age Group
10.5.6.1.3 Brazil DTaP And Tdap Vaccines Market by End user
10.5.6.2 Argentina DTaP And Tdap Vaccines Market
10.5.6.2.1 Argentina DTaP And Tdap Vaccines Market by Product Type
10.5.6.2.2 Argentina DTaP And Tdap Vaccines Market by Age Group
10.5.6.2.3 Argentina DTaP And Tdap Vaccines Market by End user
10.5.6.3 Rest of South and Central America DTaP And Tdap Vaccines Market
10.5.6.3.1 Rest of South and Central America DTaP And Tdap Vaccines Market by Product Type
10.5.6.3.2 Rest of South and Central America DTaP And Tdap Vaccines Market by Age Group
10.5.6.3.3 Rest of South and Central America DTaP And Tdap Vaccines Market by End user
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DTAP AND TDAP VACCINES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DTAP AND TDAP VACCINES MARKET, KEY COMPANY PROFILES
13.1. AJ VACCINES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIONET-ASIA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLAXOSMITHKLINE PLC (GSK)
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. JOHNSON AND JOHNSON
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MASSBIOLOGICS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEIJI HOLDINGS CO., LTD. (KM BIOLOGICS CO., LTD.)
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MERCK AND CO., INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PANACEA BIOTEC LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SANOFI
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SERUM INSTITUTE OF INDIA PVT. LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. AJ Vaccines
2. Bionet-Asia
3. GlaxoSmithKline plc (GSK)
4. Johnson & Johnson
5. Massbiologics
6. Meiji Holdings Co., Ltd. (KM biologics co., Ltd.)
7. Merck & Co., Inc.
8. Panacea Biotec Ltd.
9. Sanofi
10. Serum Institute of India Pvt. Ltd.
11. Protein Sciences Corporation
12. Novartis AG
13. Seqirus
14. Astellas Pharma US
15. Lanzhou Institute of Biological Products Co., Ltd
16. AstraZeneca
17. Emergent BioSolutions Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For